510(k) Report

510(k) · Cleared

Cleared

FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor a, Clone EPI, RTU (Dako Onmis)

K170028510(k) TraditionalCleared Dec 21, 2017352-day reviewClass II21 CFR 864.1860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dako Denmark A/S · MYA Immunohistochemistry Antibody Assay, Estrogen Receptor

Cleared on Dec 21, 2017 as substantially equivalent to K120663 (Dako North America, Inc., 2013) after a 352-day review. Its family tree reaches back 4 generations to 1988.

Decided
Dec 21, 2017
Review
352 days
Class
Class II
Product code
MYA
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to P880026 (1988). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backP880026 Abbott ER-Ica MonoclonalAbbott Laboratories · 1988
  2. 3 generations backK984567 Ventana ER Primary Antibody (Clone 6F11)Ventana, Inc. · 1999 · Recalled
  3. 2 generations backK042884 Dakocytomation ER/PR Pharmdx KitDakocytomation California, Inc. · 2005
  4. 1 generation backK120663 Monoclonal Rabbit Anti-Human Estrogen Receptor (ER) a, Clone EpiDako North America, Inc. · 2013
  5. This deviceK170028 FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor a, Clone EPI…Dako Denmark A/S · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4P880026Abbott ER-Ica MonoclonalAbbott Laboratories1988—
−3K984567Ventana ER Primary Antibody (Clone 6F11)Ventana, Inc.19992
−2K042884Dakocytomation ER/PR Pharmdx KitDakocytomation California, Inc.2005—
−1K120663Monoclonal Rabbit Anti-Human Estrogen Receptor (ER) a, Clone EpiDako North America, Inc.2013—
0 (this device)K170028FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor a, Clone EPI, RTU (Dako…Dako Denmark A/S2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
200010
200210
FIG. 1 — Lineage of K170028, 1988–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MYA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120663Monoclonal Rabbit Anti-Human Estrogen Receptor (ER) a, Clone Epi
Summary page 5
…to-Use (RTU) Link FDA Product code: MYA Classification: Class II (21 CFR 864.1860) Device Cleared in Premarket notification K120663. Device Description The FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor α, Clone EP1, Ready-to-Use (Dako Omnis) antibody is…
Dako North America, Inc.2013—

Also cleared against K120663: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 5 companies; a new generation was cleared every 8.0 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 1 other device also cites its predicate K120663.

How does its category compare?

All MYA devices

MYA Immunohistochemistry Antibody Assay, Estrogen Receptor: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · MYA

1in 2018

2009: 12012: 12013: 12014: 12017: 12018: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MYA

Too few MYA 510(k)s in any year since 2007 to give a median.

Recalls per year · MYA

2in 2011

2011: 2
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MYA

2in 2025

2012: 12014: 12015: 12016: 12017: 22018: 12021: 22023: 12024: 32025: 2
2007high 3 (2024) · low 0 (2007)2025

MAUDE reports naming product code MYA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20100—00
20110—20
20121—01
20131—00
20141—01
20150—01
20160—01
20171—02
20181—01
20190—00
20200—00
20210—02
20220—00
20230—01
20240—03
20250—02
20260—0—

What is it indicated for?

For in vitro diagnostic use. FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor α, Clone EP1, Ready-to-Use (Dako Omnis), is intended for use in immunohistochemistry with the EnVision FLEX visualization system together with the Dako Omnis instrument to qualitatively detect human estrogen receptor in formalin-fixed, paraffin-embedded tissue sections of human breast cancer. The antibody binds estrogen receptor α expressing cells and is useful in the…

Read the full statement (133 words)

For in vitro diagnostic use.

FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor α, Clone EP1, Ready-to-Use (Dako Omnis), is intended for use in immunohistochemistry with the EnVision FLEX visualization system together with the Dako Omnis instrument to qualitatively detect human estrogen receptor in formalin-fixed, paraffin-embedded tissue sections of human breast cancer.

The antibody binds estrogen receptor α expressing cells and is useful in the assessment of estrogen receptor status in human breast carcinomas.

The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist. This antibody is intended to be used after the primary diagnosis of tumor has been made by conventional histopathology using nonimmunologic histochemical stains.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K170028: FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor a, Clone EPI, RTU (Dako Onmis).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170028

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026